REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental antibody therapy shows promise for Hard-to-Treat leukemia
Disease control TerminatedThis study tested a new drug called ADCT-602 in 37 adults with B-cell acute lymphoblastic leukemia that had returned or stopped responding to treatment. The drug is an antibody that targets a protein called CD22 on leukemia cells, aiming to stop their growth. The main goals were …
Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:46 UTC
-
New hope for tough leukemia: drug combo shows promise in early trial
Disease control TerminatedThis study tested a combination of a targeted drug (venetoclax) with low-intensity chemotherapy in adults with acute lymphoblastic leukemia (ALL) that had returned or not responded to prior treatment. The goal was to find the safest dose and see how well the combo works. The tria…
Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:22 UTC